# To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.

> **NCT00296361** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 634 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00296361
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 634 (ACTUAL)
- **Last updated:** 2014-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296361, "To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00296361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*